Poster Session 3-17 Post-transplant: Relapse/Secondary Malignancy/Others

[PS3-17-7] Risk factors of allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes

Haruka Teshigawara¹, Maki Hagihara¹, Hiroshi Teranaka¹, Jun Aoki², Satoshi Koyama¹, Hiroyuki Takahashi¹, Yuki Nakajima², Hiroyoshi Kunimoto¹, Takayoshi Tachibana³, Takuya Miyazaki¹, Kenji Matsumoto¹, Masatsugu Tanaka¹, Etsuko Yamazaki⁴, Jun Taguchi⁵, Shin Fujisawa², Heiwa Kanamori³, Hideaki Nakajima¹ (1.Hematology and Clinical Immunology, Yokohama City University, Yokohama, Japan, 2.Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan, 3.Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan, 4.Department of Laboratory Medicine, Yokohama City University Hospital, Yokohama, Japan, 5.Department of Hematology, Shizuoka Red Cross Hospital)